Aker BioMarine Balance Sheet Health
Financial Health criteria checks 4/6
Aker BioMarine has a total shareholder equity of $189.7M and total debt of $150.2M, which brings its debt-to-equity ratio to 79.2%. Its total assets and total liabilities are $409.0M and $219.3M respectively. Aker BioMarine's EBIT is $4.6M making its interest coverage ratio 0.3. It has cash and short-term investments of $14.9M.
Key information
79.2%
Debt to equity ratio
US$150.20m
Debt
| Interest coverage ratio | 0.3x |
| Cash | US$14.90m |
| Equity | US$189.70m |
| Total liabilities | US$219.30m |
| Total assets | US$409.00m |
Recent financial health updates
Recent updates
Aker BioMarine AS' (OB:AKBM) Share Price Boosted 34% But Its Business Prospects Need A Lift Too
Dec 20
Aker BioMarine (OB:AKBM) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Nov 08Aker BioMarine AS' (OB:AKBM) Revenues Are Not Doing Enough For Some Investors
Nov 05At kr102, Is It Time To Put Aker BioMarine AS (OB:AKBM) On Your Watch List?
Aug 20Optimistic Investors Push Aker BioMarine AS (OB:AKBM) Shares Up 25% But Growth Is Lacking
Jul 19What Does The Future Hold For Aker BioMarine AS (OB:AKBM)? These Analysts Have Been Cutting Their Estimates
Jul 16There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital
Jul 11These 4 Measures Indicate That Aker BioMarine (OB:AKBM) Is Using Debt In A Risky Way
Jun 03There's No Escaping Aker BioMarine AS' (OB:AKBM) Muted Revenues
Feb 15There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital
Nov 06Estimating The Fair Value Of Aker BioMarine AS (OB:AKBM)
Sep 06We Think You Should Be Aware Of Some Concerning Factors In Aker BioMarine's (OB:AKBM) Earnings
Nov 04Aker BioMarine AS' (OB:AKBM) Has Found A Path To Profitability
Apr 13Aker BioMarine AS (OB:AKBM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Feb 18Loss-Making Aker BioMarine AS (OB:AKBM) Set To Breakeven
Jan 07Financial Position Analysis
Short Term Liabilities: AKBM's short term assets ($223.7M) exceed its short term liabilities ($60.8M).
Long Term Liabilities: AKBM's short term assets ($223.7M) exceed its long term liabilities ($158.5M).
Debt to Equity History and Analysis
Debt Level: AKBM's net debt to equity ratio (71.3%) is considered high.
Reducing Debt: AKBM's debt to equity ratio has reduced from 227.8% to 79.2% over the past 5 years.
Debt Coverage: AKBM's debt is well covered by operating cash flow (34.6%).
Interest Coverage: AKBM's interest payments on its debt are not well covered by EBIT (0.3x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 08:01 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Aker BioMarine AS is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |
| Ole-Andreas Krohn | DNB Markets |
| Ola Trovatn | DNB Markets |